Dec 16, 2025 | News EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
BioPharm International,
The European Commission (EC) has approved a subcutaneous, self-administered formulation of anifrolumab (brand name Saphnelo…
The European Commission (EC) has approved a subcutaneous, self-administered formulation of anifrolumab (brand name Saphnelo…
Two relatively simple interventions — addressing high blood pressure (BP) and smoking cessation — could make a huge difference…
Two relatively simple interventions — addressing high blood pressure (BP) and smoking cessation — could make a huge difference…
Action Points Note that this cohort study of newly diagnosed individuals with systemic lupus erythematosus found that higher…